Thermo Fisher Scientific to Acquire The Binding Site Group for £2.25B in Cash
Once acquired, the Birmingham, UK-based blood cancer and immune disease diagnostics company will become part of Thermo Fisher's specialty diagnostics segment.
Stay updated with breaking news from Marc Casper. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Once acquired, the Birmingham, UK-based blood cancer and immune disease diagnostics company will become part of Thermo Fisher's specialty diagnostics segment.
Thermo Fisher Scientific Inc. (NYSE:NYSE:TMO) Q3 2022 Earnings Conference Call October 26, 2022 08:30 ET Company Participants Rafael Tejada - Vice President, Investor Relations Marc Casper...
TMO earnings call for the period ending September 30, 2022.
Thermo Fisher expects to add about 300 jobs through the facility, which will support the development and commercialization of gene therapies.
Thermo Fisher Scientific earnings call for the period ending June 30, 2022.